Bain Is Said to Near $3 Billion Deal for Mitsubishi Pharma Unit
- Firms are aiming to announce an agreement as soon as Friday
- Potential deal would add to ongoing dealmaking boom in Japan
This article is for subscribers only.
Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter said, adding to a dealmaking boom in Japan.
The US-based private equity firm and Mitsubishi are finalizing details of a transaction that could be announced as soon as Friday, the people said, asking not to be identified because the information is private. A deal could value Mitsubishi Tanabe Pharma at more than ¥500 billion yen ($3.3 billion), the people said.